{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03399",
      "entity_text" : "VTE",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:439260",
      "entity_text" : "noradrenaline",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In previous studies, we found that systemic clonidine, an alpha2 noradrenergic auto-receptor agonist, which decreases tonic noradrenaline levels, behaviorally and mentally suppressed VTE processes--both the behavioral manifestation of VTE and the forward representations in hippocampus within theta cycles.",
  "reading_complete" : "2020-08-08T10:14:28Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T10:10:35Z",
  "trigger" : "suppressed",
  "evidence" : [ "noradrenaline levels              , behaviorally and mentally suppressed VTE" ],
  "pmc_id" : "5929482",
  "score" : 0
}